LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,930
تعداد دریافت فایل اصل مقاله11,291,565
Akbarzadeh, Marzieh, Eftekhari, Mohammad Hassan, Dabbaghmanesh, Mohammad Hossein, Hasanzadeh, Jafar, Bakhshayeshkaram, Marzieh. (1392). Serum IL-18 and hsCRP Correlate with Insulin Resistance without Effect of Calcitriol Treatment on Type 2 Diabetes. سامانه مدیریت نشریات علمی, 10(3), 167-176.
Marzieh Akbarzadeh; Mohammad Hassan Eftekhari; Mohammad Hossein Dabbaghmanesh; Jafar Hasanzadeh; Marzieh Bakhshayeshkaram. "Serum IL-18 and hsCRP Correlate with Insulin Resistance without Effect of Calcitriol Treatment on Type 2 Diabetes". سامانه مدیریت نشریات علمی, 10, 3, 1392, 167-176.
Akbarzadeh, Marzieh, Eftekhari, Mohammad Hassan, Dabbaghmanesh, Mohammad Hossein, Hasanzadeh, Jafar, Bakhshayeshkaram, Marzieh. (1392). 'Serum IL-18 and hsCRP Correlate with Insulin Resistance without Effect of Calcitriol Treatment on Type 2 Diabetes', سامانه مدیریت نشریات علمی, 10(3), pp. 167-176.
Akbarzadeh, Marzieh, Eftekhari, Mohammad Hassan, Dabbaghmanesh, Mohammad Hossein, Hasanzadeh, Jafar, Bakhshayeshkaram, Marzieh. Serum IL-18 and hsCRP Correlate with Insulin Resistance without Effect of Calcitriol Treatment on Type 2 Diabetes. سامانه مدیریت نشریات علمی, 1392; 10(3): 167-176.

Serum IL-18 and hsCRP Correlate with Insulin Resistance without Effect of Calcitriol Treatment on Type 2 Diabetes

Iranian Journal of Immunology
مقاله 5، دوره 10، شماره 3، آذر 2013، صفحه 167-176    اصل مقاله (224.92 K)
نوع مقاله: Original Article
نویسندگان
Marzieh Akbarzadeh1؛ Mohammad Hassan Eftekhari1؛ Mohammad Hossein Dabbaghmanesh* 2؛ Jafar Hasanzadeh3؛ Marzieh Bakhshayeshkaram* 2
1Department of Nutrition, School of Health and Nutrition
2Endocrine and Metabolism Research Center, Nemazee Hospital
3Epidemiology Department, School of Health and Nutrition, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Chronic low-grade systemic inflammation presented in Type 2 diabetes mellitus plays a major role in disease progression as well as development of micro- and macro-vascular complications of diabetes. Therefore, reducing inflammation can be beneficial in prevention of diabetes complications.
Objectives: To investigate the association between insulin resistance and inflammatory markers, and assessing the effects of oral Calcitriol on inflammatory cytokines in type 2 diabetic patients.
Methods: In this double-blind randomized placebo-controlled trial, 70 participants with type-2 diabetes were randomly divided to two groups. One group received two capsules of Calcitriol (0.25 μg 1,25-dihydroxy cholecalciferol per each capsule) per day. The second group received placebo tablets. At the beginning of the study, we assessed insulin resistance and its relation to inflammatory profile. Serum high sensitive Creactive protein (hs CRP), interleukin-6 and interleukin-18 were also measured at the beginning and the end of the 12-week supplementation trial.
Results: Mean calcium, phosphorus and vitamin D concentrations in the study participants were 8.98 ± 0.79 mg/dl, 3.86 ± 0.50 mg/dl and 40.91 ± 30.9 ng/ml, respectively. IL-18 and hsCRP had significant positive associations with insulin resistance markers and negative associations with insulin sensitivity markers. At the end of the 12-week supplementation trial, no significant difference was seen in serum levels of hsCRP, IL-6 and IL-18 between the two groups, while these values were adjusted for baseline values.
Conclusion: Inflammation was associated with insulin resistance in diabetic patients. No anti-inflammatory effect of Calcitriol in terms of decreasing hsCRP, IL-6 and IL-18 detected.
کلیدواژه‌ها
Type 2 Diabetes؛ IL-18؛ IL-6
آمار
تعداد مشاهده مقاله: 1,664
تعداد دریافت فایل اصل مقاله: 1,095


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب